You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華森製藥(002907.SZ):公司藥品生產許可證變更
格隆匯 11-12 19:46

格隆匯 11 月 12日丨華森製藥(002907.SZ)公佈,公司於2020年11月10日收到重慶市藥品監督管理局頒發的新版《藥品生產許可證》(許可證編號:渝20150018),此次主要涉生產範圍的變更。變更內容如下:

(一)新版生產許可證正文內容新增:質量授權人:鄧林,生產負責人:周幫建。

(二)在生產地址重慶市榮昌區工業園區上增加生產範圍:中藥前處理及提取***;(注:公司於該生產地址原擁有中藥前處理及提取的相關批件,原版生產許可證無需載明該項內容,此次新版生產許可證應相關政府部門要求予以載明。)

(三)在生產地址榮昌區昌州街道板橋路143號增加生產範圍:中藥前處理及提取***;

(四)新版生產許可證(副本)增加的其他內容:車間和生產線情況,委託或受託情況。

其他內容不變***

此次換版《藥品生產許可證》涉及公司第五期新建GMP生產基地項目生產範圍的增加,有利於公司優化生產結構,繼續保持穩定的生產能力,滿足市場需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account